Загрузка...
The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer
The tyrosine kinase receptor A (NTRK1/TrkA) is increasingly regarded as a therapeutic target in oncology. In breast cancer, TrkA contributes to metastasis but the clinicopathological significance remains unclear. In this study, TrkA expression was assessed via immunohistochemistry of 158 invasive du...
Сохранить в:
| Опубликовано в: : | Biomolecules |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7564775/ https://ncbi.nlm.nih.gov/pubmed/32957504 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom10091329 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|